Trials / Completed
CompletedNCT03547141
Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers
A Randomized, Double-blind, Active-controlled, Single-center, Phase 1 Study to Determine the Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To determine the pharmacodynamic and safety of MBA-P01 in Healthy Male Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MBA-P01 | injection of MBA-P01 into the muscle of each contralateral foot in equal doses |
| DRUG | BOTOX | injection of BOTOX into the muscle of each contralateral foot in equal doses |
Timeline
- Start date
- 2018-04-16
- Primary completion
- 2018-08-28
- Completion
- 2018-11-01
- First posted
- 2018-06-06
- Last updated
- 2019-03-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03547141. Inclusion in this directory is not an endorsement.